| Industry Range | | Price / Earnings | N/A | |
| Book Value | 1.05 | |
| Earnings Per Share | -$1.02 | |
| Price To Sales Ratio | 4.92 | |
| Price To Book Ratio | 3.06 | |
| Price To Tangible Book Ratio | 3.52 | |
| Price/Cash Flow Ratio | N/A | |
| Price/Free Cash Flow Ratio | N/A | |
| Industry Range | | Market Capitalization | 91.3M | |
| Float (MRQ) | 70.21% | |
| Shares Outstanding (MRQ) | 101.4M | |
| Short Interest as a % of Float (MRQ) | 3.50% | |
| Shares Held By Institutions (MRQ) | 33.5M | |
| Industry Range | | Sales | $68.8M | |
| Gross Margin | 49.54% | |
| Net Profit Margin | -94.06% | |
| EBIT Margin | -268.64% | |
| EBITDA Margin | -258.76% | |
| Operating Margins | -268.64% | |
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K
statement or press releases. MRQ = Most Recent Quarter
| Industry Range | | Current Ratio (MRQ) | 3.43 | |
| Quick Ratio (MRQ) | 3.33 | |
| Total Debt/Equity Ratio (MRQ) | 68.99 | |
| Debt/Common Equity Ratio (MRQ) | 68.99 | |
| Industry Range | | Return on Equity | -62.29% | |
| Return on Assets | -20.13% | |
| Asset Turnover | 0.21 | |
| Receivables Turnover | 2.74 | |
| Inventory Turnover | 3.65 | |
| Industry Range | | EPS Growth Annual | 23.44% | |
| Dividend Yield 5 Year Average | 0.00% | |
| Current Dividend Yield | 0.00% | |
| Current Payout Ratio | N/A | |
*FBIO does not pay a dividend. The average dividend yield for companies in the Pharmaceuticals: Major industry is 2.22%